• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前使用氯胺酮和电休克疗法可快速缓解重度重度抑郁症。

Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapy.

作者信息

Goforth Harold W, Holsinger Tracey

机构信息

Duke University Medical Center, and Consultation-Liaison Psychiatry Service, Durham Veterans Affairs Medical Center, Durham, NC 27710, USA.

出版信息

J ECT. 2007 Mar;23(1):23-5. doi: 10.1097/01.yct.0000263257.44539.23.

DOI:10.1097/01.yct.0000263257.44539.23
PMID:17435569
Abstract

Major depressive disorder is a difficult-to-treat and recurrent debilitating disorder. All approved somatic treatments for major depression to date require a significant time lapse before demonstrating an antidepressant effect. However, emerging evidence indicates a potential role for the use of ketamine to rapidly relieve symptoms of major depression. We present a case of severe, recurrent major depressive disorder that demonstrated marked improvement within 8 hours of receiving a preoperative dose of ketamine and 1 treatment of electroconvulsive therapy with bitemporal electrode placement. This case is supportive of a role of ketamine in relieving symptoms of major depressive disorder rapidly and safely.

摘要

重度抑郁症是一种难以治疗且反复发作的使人衰弱的疾病。迄今为止,所有已获批的用于治疗重度抑郁症的躯体治疗方法在显示出抗抑郁效果之前都需要相当长的时间间隔。然而,新出现的证据表明,使用氯胺酮快速缓解重度抑郁症症状具有潜在作用。我们报告一例严重的、复发性重度抑郁症病例,该病例在接受术前剂量的氯胺酮和一次采用双侧颞部电极放置的电休克治疗后8小时内症状显著改善。该病例支持氯胺酮在快速且安全地缓解重度抑郁症症状方面的作用。

相似文献

1
Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapy.术前使用氯胺酮和电休克疗法可快速缓解重度重度抑郁症。
J ECT. 2007 Mar;23(1):23-5. doi: 10.1097/01.yct.0000263257.44539.23.
2
Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.重复给予氯胺酮与电抽搐治疗对住院的重性抑郁障碍患者的快速抗抑郁作用比较。
Psychiatry Res. 2014 Feb 28;215(2):355-61. doi: 10.1016/j.psychres.2013.12.008. Epub 2013 Dec 13.
3
Ketamine followed by memantine for the treatment of major depression.氯胺酮后用美金刚治疗重度抑郁症。
Aust N Z J Psychiatry. 2008 Feb;42(2):170. doi: 10.1080/00048670701787628.
4
Comparison of racemic ketamine and S-ketamine in treatment-resistant major depression: report of two cases.比较外消旋氯胺酮和 S-氯胺酮治疗难治性重度抑郁症:两例报告。
World J Biol Psychiatry. 2009;10(3):241-4. doi: 10.1080/15622970701714370.
5
Two case studies of patients with major depressive disorder given low-dose (subanesthetic) ketamine infusions.两项关于重度抑郁症患者接受低剂量(亚麻醉剂量)氯胺酮输注的病例研究。
Pain Med. 2006 Jan-Feb;7(1):92-5. doi: 10.1111/j.1526-4637.2006.00101.x.
6
[Ketamine in acute and severe major depressive disorder].[氯胺酮治疗急性重度重度抑郁症]
Presse Med. 2014 May;43(5):492-500. doi: 10.1016/j.lpm.2013.11.013. Epub 2014 Mar 12.
7
Electroconvulsive therapy for comorbid major depressive disorder and posttraumatic stress disorder.电休克治疗共病的重度抑郁症和创伤后应激障碍
J ECT. 2007 Jun;23(2):93-5. doi: 10.1097/01.yct.0000264369.38033.34.
8
Comparison of ketamine vs. ECT in major depressive disorder: need for ECT standard dosing and duration parameters.氯胺酮与电休克疗法治疗重度抑郁症的比较:电休克疗法标准剂量和持续时间参数的必要性。
Psychiatry Res. 2015 Jan 30;225(1-2):216. doi: 10.1016/j.psychres.2014.08.023.
9
Speed of response to electroconvulsive therapy compared with ketamine.与氯胺酮相比,电休克治疗的反应速度
Psychiatry Res. 2015 Jan 30;225(1-2):215. doi: 10.1016/j.psychres.2014.08.021.
10
Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression: A Case Report.交替静脉注射消旋氯胺酮与电休克治疗难治性抑郁症后的强效抗抑郁作用:一例报告
J ECT. 2017 Sep;33(3):e31-e32. doi: 10.1097/YCT.0000000000000421.

引用本文的文献

1
Comparing the sedative and analgesic effects of ketorolac and diclofenac eye drops among patients with cataract surgery: A double-blind randomized clinical trial.比较酮咯酸和双氯芬酸滴眼液在白内障手术患者中的镇静和镇痛效果:一项双盲随机临床试验。
Oman J Ophthalmol. 2024 Oct 24;17(3):342-347. doi: 10.4103/ojo.ojo_246_23. eCollection 2024 Sep-Dec.
2
Case series of intravenous ketamine infusion in patients with suicidal thought.有自杀念头患者静脉注射氯胺酮的病例系列
Ind Psychiatry J. 2023 Jul-Dec;32(2):437-440. doi: 10.4103/ipj.ipj_19_23. Epub 2023 Oct 4.
3
Ketamine produces no detectable long-term positive or negative effects on cognitive flexibility or reinforcement learning of male rats.
氯胺酮对雄性大鼠的认知灵活性或强化学习没有产生可检测的长期正或负面影响。
Psychopharmacology (Berl). 2024 Apr;241(4):849-863. doi: 10.1007/s00213-023-06514-4. Epub 2023 Dec 8.
4
A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder.自闭症谱系障碍中分子信号转导功能障碍的观点及其临床意义和治疗。
Exp Brain Res. 2022 Oct;240(10):2525-2567. doi: 10.1007/s00221-022-06448-x. Epub 2022 Sep 5.
5
S -ketamine compared to etomidate during electroconvulsive therapy in major depression.S-氯胺酮与依托咪酯在重度抑郁症电抽搐治疗中的比较。
Eur Arch Psychiatry Clin Neurosci. 2017 Dec;267(8):803-813. doi: 10.1007/s00406-017-0800-3. Epub 2017 Apr 19.
6
Antidepressant Effect of Combined Ketamine and Electroconvulsive Therapy on Patients With Major Depressive Disorder: A Randomized Trial.氯胺酮联合电休克治疗对重度抑郁症患者的抗抑郁作用:一项随机试验
Iran J Psychiatry Behav Sci. 2015 Sep;9(3):e1578. doi: 10.17795/ijpbs-1578. Epub 2015 Sep 23.
7
Use of ketamine in acute cases of suicidality.氯胺酮在急性自杀倾向病例中的应用。
Innov Clin Neurosci. 2015 Jan-Feb;12(1-2):29-31.
8
A molecular pathway analysis of the glutamatergic-monoaminergic interplay serves to investigate the number of depressive records during citalopram treatment.对谷氨酸能-单胺能相互作用的分子通路分析有助于研究西酞普兰治疗期间的抑郁记录数量。
J Neural Transm (Vienna). 2015 Mar;122(3):465-75. doi: 10.1007/s00702-014-1267-2. Epub 2014 Jul 2.
9
Post-electroconvulsive therapy recovery and reorientation time with methohexital and ketamine: a randomized, longitudinal, crossover design trial.美索比妥和氯胺酮用于电休克治疗后的恢复及重新定向时间:一项随机、纵向、交叉设计试验
J ECT. 2015 Mar;31(1):20-5. doi: 10.1097/YCT.0000000000000132.
10
Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy.氯胺酮作为原型谷氨酸能抗抑郁药:药效学作用及疗效的系统评价与荟萃分析。
Ther Adv Psychopharmacol. 2014 Apr;4(2):75-99. doi: 10.1177/2045125313507739.